Cargando…

Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression

SIMPLE SUMMARY: Meningioma (MN) is the most frequent primary brain tumor with a high frequency of recurrences and a lack of objective tools for predicting their prognosis. In this study, we analyzed a careful selection of patients in which both the primary tumor and at least one recurrence were avai...

Descripción completa

Detalles Bibliográficos
Autores principales: San-Miguel, Teresa, Megías, Javier, Monleón, Daniel, Navarro, Lara, Muñoz-Hidalgo, Lisandra, Montoliu, Carmina, Meri, Marina, Roldán, Pedro, Cerdá-Nicolás, Miguel, López-Ginés, Concha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406329/
https://www.ncbi.nlm.nih.gov/pubmed/36011000
http://dx.doi.org/10.3390/cancers14164008
_version_ 1784774094051344384
author San-Miguel, Teresa
Megías, Javier
Monleón, Daniel
Navarro, Lara
Muñoz-Hidalgo, Lisandra
Montoliu, Carmina
Meri, Marina
Roldán, Pedro
Cerdá-Nicolás, Miguel
López-Ginés, Concha
author_facet San-Miguel, Teresa
Megías, Javier
Monleón, Daniel
Navarro, Lara
Muñoz-Hidalgo, Lisandra
Montoliu, Carmina
Meri, Marina
Roldán, Pedro
Cerdá-Nicolás, Miguel
López-Ginés, Concha
author_sort San-Miguel, Teresa
collection PubMed
description SIMPLE SUMMARY: Meningioma (MN) is the most frequent primary brain tumor with a high frequency of recurrences and a lack of objective tools for predicting their prognosis. In this study, we analyzed a careful selection of patients in which both the primary tumor and at least one recurrence were available, allowing us to extend the changes that occur during tumor progression. We developed a histological, genetic, and epigenetic analysis of the samples. Thus, we identified markers of quick recurrence, increased tumor instability by copy number alterations, and the accumulation of epigenetic changes during tumor progression. Interestingly, the genes involved seemed to be randomly distributed along the genome but eventually suggest a common impact on cell-death programs such as apoptosis and autophagy. ABSTRACT: Meningioma (MN) is an important cause of disability, and predictive tools for estimating the risk of recurrence are still scarce. The need for objective and cost-effective techniques addressed to this purpose is well known. In this study, we present methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) as a friendly method for deepening the understanding of the mechanisms underlying meningioma progression. A large follow-up allowed us to obtain 50 samples, which included the primary tumor of 20 patients in which half of them are suffering one recurrence and the other half are suffering more than one. We histologically characterized the samples and performed MS-MLPA assays validated by FISH to assess their copy number alterations (CNA) and epigenetic status. Interestingly, we determined the increase in tumor instability with higher values of CNA during the progression accompanied by an increase in epigenetic damage. We also found a loss of HIC1 and the hypermethylation of CDKN2B and PTEN as independent prognostic markers. Comparison between grade 1 and higher primary MN’s self-evolution pointed to a central role of GSTP1 in the first stages of the disease. Finally, a high rate of alterations in genes that are related to apoptosis and autophagy, such as DAPK1, PARK2, BCL2, FHIT, or VHL, underlines an important influence on cell-death programs through different pathways.
format Online
Article
Text
id pubmed-9406329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94063292022-08-26 Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression San-Miguel, Teresa Megías, Javier Monleón, Daniel Navarro, Lara Muñoz-Hidalgo, Lisandra Montoliu, Carmina Meri, Marina Roldán, Pedro Cerdá-Nicolás, Miguel López-Ginés, Concha Cancers (Basel) Article SIMPLE SUMMARY: Meningioma (MN) is the most frequent primary brain tumor with a high frequency of recurrences and a lack of objective tools for predicting their prognosis. In this study, we analyzed a careful selection of patients in which both the primary tumor and at least one recurrence were available, allowing us to extend the changes that occur during tumor progression. We developed a histological, genetic, and epigenetic analysis of the samples. Thus, we identified markers of quick recurrence, increased tumor instability by copy number alterations, and the accumulation of epigenetic changes during tumor progression. Interestingly, the genes involved seemed to be randomly distributed along the genome but eventually suggest a common impact on cell-death programs such as apoptosis and autophagy. ABSTRACT: Meningioma (MN) is an important cause of disability, and predictive tools for estimating the risk of recurrence are still scarce. The need for objective and cost-effective techniques addressed to this purpose is well known. In this study, we present methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) as a friendly method for deepening the understanding of the mechanisms underlying meningioma progression. A large follow-up allowed us to obtain 50 samples, which included the primary tumor of 20 patients in which half of them are suffering one recurrence and the other half are suffering more than one. We histologically characterized the samples and performed MS-MLPA assays validated by FISH to assess their copy number alterations (CNA) and epigenetic status. Interestingly, we determined the increase in tumor instability with higher values of CNA during the progression accompanied by an increase in epigenetic damage. We also found a loss of HIC1 and the hypermethylation of CDKN2B and PTEN as independent prognostic markers. Comparison between grade 1 and higher primary MN’s self-evolution pointed to a central role of GSTP1 in the first stages of the disease. Finally, a high rate of alterations in genes that are related to apoptosis and autophagy, such as DAPK1, PARK2, BCL2, FHIT, or VHL, underlines an important influence on cell-death programs through different pathways. MDPI 2022-08-19 /pmc/articles/PMC9406329/ /pubmed/36011000 http://dx.doi.org/10.3390/cancers14164008 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
San-Miguel, Teresa
Megías, Javier
Monleón, Daniel
Navarro, Lara
Muñoz-Hidalgo, Lisandra
Montoliu, Carmina
Meri, Marina
Roldán, Pedro
Cerdá-Nicolás, Miguel
López-Ginés, Concha
Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title_full Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title_fullStr Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title_full_unstemmed Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title_short Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
title_sort matched paired primary and recurrent meningiomas points to cell-death program contributions to genomic and epigenomic instability along tumor progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406329/
https://www.ncbi.nlm.nih.gov/pubmed/36011000
http://dx.doi.org/10.3390/cancers14164008
work_keys_str_mv AT sanmiguelteresa matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT megiasjavier matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT monleondaniel matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT navarrolara matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT munozhidalgolisandra matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT montoliucarmina matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT merimarina matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT roldanpedro matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT cerdanicolasmiguel matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression
AT lopezginesconcha matchedpairedprimaryandrecurrentmeningiomaspointstocelldeathprogramcontributionstogenomicandepigenomicinstabilityalongtumorprogression